NCT05203796View on ClinicalTrials.gov

The Evaluation of the Transcutaneous Electrical Stimulation Medical Device's Safety and Effectiveness in Treating the Patients With Dry Eye Disease

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 23, 2021

Primary Completion Date

January 26, 2022

Study Completion Date

January 26, 2022

Conditions
Dry Eye Disease
Interventions
DEVICE

Transcutaneous pulsed electrical stimulation (NuEyne 02)

Arm 1: Experimental: Experimental group: Dry eye disease patients (n=12) Device: Pulse Electrical Stimulation Pulse Electrical Stimulation: Patients wear our clinical trial device 30mins once a day for 4 weeks.

DEVICE

Sham stimulation

Arm 2: Sham Comparator: Comparison group: Dry eye disease patients (n=12) Device: Sham stimulation Sham stimulation: Patients wear our clinical trial device 30mins once a day for 4 weeks.

Trial Locations (1)

06351

Department of Ophthalmology, Samsung Medical Center, Seoul

All Listed Sponsors
lead

Nu Eyne Co., Ltd.

INDUSTRY

NCT05203796 - The Evaluation of the Transcutaneous Electrical Stimulation Medical Device's Safety and Effectiveness in Treating the Patients With Dry Eye Disease | Biotech Hunter | Biotech Hunter